`
`Page 1 of 40
`
`Curriculum Vitae
`
`Diana V. Do, M.D.
`
`
`
`
`Professor, Medical Center Line
`Byers Eye Institute
`Department of Ophthalmology
`Stanford University
`
`Vice Chair of Clinical Affairs
`Byers Eye Institute
`Department of Ophthalmology
`Stanford University
`
`Physician Improvement Leader
`Byers Eye Institute
`Department of Ophthalmology
`Stanford University
`
`
`Personal Information
`
`Address:
`Byers Eye Institute
`Department of Ophthalmology
`Stanford University School of Medicine
`2370 Watson Court
`Suite #228
`Palo Alto, California 94303-3216
`Phone: 650-725-7245
`Cell: 443-690-0167
`
`E-mail: dianado@stanford.edu
`
`Administrative Assistant: Ms. Genai Bigornia, genaib@stanford.edu, 650-725-7245
`
`
`Present Academic Rank and Positions
`
`01/2017-now
`
`
`
`
`
`
`
`
`
`
`01/2019-now
`
`
`
`
`
`
`
`
`
`
`01/2018-now
`
`
`
`
`
`
`
`
`
`
`Prior Professional Appointments
`
`01/2015-12/2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Professor of Ophthalmology
`Vice-Chair for Education
`Director of Carl Camras Center for Innovative Clinical Research
`Director of Ophthalmology Residency Training Program
`Director of Retina Fellowship Training Program
`Truhlsen Eye Institute
`Department of Ophthalmology and Visual Sciences
`University of Nebraska College of Medicine
`Omaha, Nebraska
`
`
`
`
`
`
`
`
`
`
`
`
`Regeneron Exhibit 2002
`Page 01 of 40
`
`

`

`Diana V. Do, MD
`February 8, 2021
`
`
`
`
`2
`
`
`
`
`Associate Professor of Ophthalmology
`Vice-Chair for Education
`Director of Carl Camras Center for Innovative Clinical Research
`Director of Ophthalmology Residency Training Program
`Truhlsen Eye Institute
`Department of Ophthalmology and Visual Sciences
`University of Nebraska College of Medicine
`Omaha, Nebraska
`
`Associate Professor of Ophthalmology
`Head of the Retina Fellowship Training Program
`The Wilmer Eye Institute
`The Johns Hopkins University School of Medicine
`Baltimore, Maryland
`
`Assistant Professor of Ophthalmology
`Assistant Head of the Retina Fellowship Training Program
`The Wilmer Eye Institute
`The Johns Hopkins University School of Medicine
`Baltimore, Maryland
`
`02/2013-12/2014
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`01/2011-01/2013
`
`
`
`
`
`
`
`
`
`
`
`
`
`07/2005-12/2010
`
`
`
`
`
`
`
`
`
`
`
`
`
`Education and Training
`
`Year
`
`09/1987 -
`06/1991
`
`09/1991 -
`05/1995
`
`
`
`
`
`09/1995 -
`05/1999
`
`
`
`
`
`07/1999 -
`06/2000
`
`
`
`07/2000 -
`06/2003
`
`
`
`Degree
`
`
`
`
`B.A.
`
`
`
`
`M.D.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Institution
`
`
`
`
`
`
`Lowell High School
`San Francisco, California
`
`
`
`
`
`Discipline
`
`
`
`Arts and Sciences
`
`University of California, Berkeley Molecular and Cell
`Berkeley, California
`
`
`
`Biology
`Summa Cum Laude
`Phi Beta Kappa
`
`
`
`
`
`University of California San Francisco Doctor of Medicine
`San Francisco, California
`University of California Regents Scholar
`Alpha Omega Alpha
`
`Internship Massachusetts General Hospital
`
`
`Harvard Medical School
`
`
`Boston, Massachusetts
`
`Internal Medicine
`
`Ophthalmology
`
`Residency Wilmer Eye Institute
`
`
`The Johns Hopkins University School of Medicine
`Baltimore, Maryland
`
`
`Retina
`
`07/ 2003 - Fellowship Wilmer Eye Institute
`06/2005
`
`
`The Johns Hopkins University School of Medicine
`Baltimore, Maryland
`Heed Clinician-Scientist Fellowship Award
`Ronald G. Michels Fellowship Foundation Award
`
`
`
`
`
`
`
`
`
`Regeneron Exhibit 2002
`Page 02 of 40
`
`

`

`Diana V. Do, MD
`February 8, 2021
`
`
`
`
`3
`
`
`
`
`
`Medical License
`State of California: C143489
`
`Board Certification
`Ophthalmology
`
`Honors and Awards (During Training)
`
`1991-1995
`
`UC Berkeley: College of Letters & Science Dean’s Honor List,
`8 semesters
`UC Berkeley: Honorary Scholarship for Academic Excellence
`UC Berkeley: Phi Beta Kappa
`UC Berkeley: graduated with highest honors (summa cum laude)
`UC Berkeley: I.L. Chaikoff Award for Outstanding Achievement and
`Excellence in Molecular & Cell Biology
`UCSF School of Medicine: UC Regents Scholarship for Outstanding
`Scholastic Performance, Achievement, and Promise as a Leader
`UCSF School of Medicine: Dean’s Summer Research Fellowship Award
`UCSF School of Medicine: Pharmacopoeia Contest Winner
`UCSF School of Medicine: Alpha Omega Alpha
`American Medical Women’s Association: Janet M. Glasgow Memorial
`Achievement Award
`ARVO/National Eye Institute Travel Fellowship
`
`2001
`2001-2002 Morton F. Goldberg Research Grant Award, The Wilmer Eye Institute
`
`
`Johns Hopkins Hospital. Competitive research grant given to residents.
`Inaugural Mitchell Prize for Outstanding Resident Research, The Wilmer
`2002
`Eye Institute, Johns Hopkins Hospital
`A. Edward Maumenee Research Grant Award, The Wilmer Eye Institute,
`Johns Hopkins Hospital. Competitive research grant given to residents.
`The W. Richard Green House Staff Teaching Award, The Wilmer Eye
`Institute, Johns Hopkins Hospital. Award given by medical students and
`faculty to most outstanding resident-teacher
`The Heed Ophthalmic Foundation 2-year Clinician-Scientist Award
`(One of 2 national awards given to the most outstanding ophthalmology
`fellow-in-training; the Heed Foundation provided funding to support my 2-
`year retina fellowship training at Wilmer)
`Ronald G. Michels Fellowship Foundation Award
`National award given to the top 3 retina fellows in the United States that
`year
`Peter J. McDonnell Research Grant Award, The Wilmer Eye Institute
`Johns Hopkins Hospital. Competitive research grant given to residents.
`Retina Fellows Forum Research Award, American Society of Retina
`Specialists. Award given to most outstanding research by a retina fellow in
`the United States that year.
`
`
`
`
`
`1993
`1995
`1995
`1995
`
`1995-1999
`
`1996
`1997
`1998
`1999
`
`
`
`
`2002
`
`2003
`
`2003-2005
`
`2004
`
`2003-2004
`
`
`2005
`
`
`
`
`
`
`
`
`Regeneron Exhibit 2002
`Page 03 of 40
`
`

`

`Diana V. Do, MD
`February 8, 2021
`
`
`
`
`4
`
`
`
`
`Honors and Awards (Since Training)
`
`2007
`
`International Michelson Symposium, Young Investigator Award.
`Competitive research grant given to young investigators.
`American Academy of Ophthalmology Achievement Award. National
`award given for contributions and service.
`President’s Award, Maryland Society of Eye Physicians and Surgeons.
`Award given for leadership, significant contribution, and service.
`Board Member, Maryland Society of Eye Physicians and Surgeons
`American Academy of Ophthalmology “Best Retina Paper” at Annual
`Meeting for my paper presentation on “VEGF Trap-Eye for Diabetic
`Macular Edema: The DA VINCI Study”
`William Evans Bruner, MD Lectureship in Ophthalmology, Case
`Western University School of Medicine, Cleveland, Ohio
`Honor Award, American Society of Retina Specialists
`Faculty Teaching Award, Byers Eye Institute, Stanford University School
`of Medicine
`Awarded by residents to honor a faculty physician for outstanding teaching
`and mentorship
`San Francisco Bay Area’s Top Doctors
`Nominated by peers as one of the top ophthalmologists in the Bay Area
`San Francisco Bay Area’s Top Doctors
`Nominated by peers as one of the top ophthalmologists in the Bay Area
`San Francisco Bay Area’s Top Doctors
`Nominated by peers as one of the top ophthalmologists in the Bay Area
`Senior Honor Award, American Society of Retina Specialists
`San Francisco Bay Area’s Top Doctors
`Nominated by peers as one of the top ophthalmologists in the Bay Area
`
`2008
`
`2010
`
`2010-2013
`2010
`
`2010
`
`2016
`2018
`
`
`
`
`
`
`
`
`
`
`
`2018
`
`2019
`
`2020
`
`2020
`2021
`
`
`Scholarly Publications
`
`Peer-review journal articles (Total: 140 ; Total at Stanford: 29)
`
`First or last author peer-review articles (Total: 62; Total at Stanford: 24)
`
`1. Do DV, Nguyen QD, Rismondo V. “Reversible Cortical Blindness in Preeclampsia.”
`American Journal of Ophthalmology 2002;134:916-918.
`
`2. Do DV, Bressler NM, Bressler SB. “Large submacular hemorrhages after verteporfin
`therapy.” American Journal of Ophthalmology. 2004;137(3)558-560.
`
`3. Do DV, Shah MS, Sung JU, Haller JA, Nguyen QD. “Persistent diabetic macular edema
`is associated with elevated hemoglobin A1c.” American Journal of Ophthalmology
`2005;139(4):620-623.
`
`4. Do DV, Nguyen QD, Bressler NM, Solomon SD, Schachat AP, Melia M, Bressler SB.
`Hemoglobin A1c awareness among patients receiving care at a tertiary ophthalmic center.
`American Journal of Ophthalmology 2006;141(5):951-953.
`
`
`Regeneron Exhibit 2002
`Page 04 of 40
`
`

`

`Diana V. Do, MD
`February 8, 2021
`
`
`
`
`5
`
`
`
`
`5. Do DV, Cho M, Nguyen QD, Shah SM, Handa JT, Campochiaro PA, Zimmer-Galler I,
`Sung J, Haller JA. Impact of optical coherence tomography on surgical decision making
`for epiretinal membranes and vitreomacular traction. Retina 2007;27(5):552-6.
`
`6. Kaiser PK, Do DV. Ranibizumab for the treatment of neovascular AMD. Int J Clin Prac
`2007;61:501-509.
`
`7. Do DV, Hawkins B, Gichuhi S, Vedula SS. Surgery for post-vitrectomy cataract.
`Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006366. Review
`
`8. Do DV, Nguyen QD, Shah SM, Browning DJ, Haller JA, Chu K, Yang K, Cederbaum J,
`Vitti RL, Ingerman A, Campochiaro PA. An exploratory study of safety, tolerability, and
`bioactivity of a single intravitreal injection of VEGF Trap eye for patients with diabetic
`macular edema. British J Ophthalmology 2009 Feb;93(2):144-9.
`
`9. Khare GD, Symons RC, Do DV. Common ophthalmic emergencies. Int J Clin Pract.
`2008 Nov;62(11):1776-84.
`
`10. Csaky K, Do DV. Safety implications of vascular endothelial growth factor blockade for
`subjects receiving intravitreal anti-vascular endothelial growth factor therapies.Am J
`Ophthalmol. 2009 Nov;148(5):647-56.
`
`11. Sabet-Peyman EJ, Nguyen QD, Do DV. Cystoid macular edema responds to
`intravitreal triamcinolone and rebounds after intravitreal bevacizumab. Ophthalmic Surg
`Lasers Imaging. 2009 Jul-Aug;40(4):413-5.
`
`12. Sabet-Peyman EJ, Heussen FM, Thorne JE, Casparis H, Patel SJ, Do DV.
`Progression of macular ischemia following intravitreal bevacizumab. Ophthalmic Surg
`Lasers Imaging. 2009 May-Jun;40(3):316-8.
`
`13. Khurana RN, Leder HA, Nguyen QD, Do DV. Enterococcus casseliflavus
`Endophthalmitis associated with a Horse tail Injury. Arch Ophthalmol. 2009
`Nov;127(11):1551-2.
`
`14. Fallano KA, Ibrahim M, Nguyen QD, Do DV. Progressive changes from idiopathic
`macular telangiectasia seen with spectral domain optical coherence tomography. Can J
`Ophthalmol. 2010 Dec 8;45(6):1-2.
`
`15. Ko FS, Sohn JH, Do DV, Resolution of Macular Edema in Radiation Retinopathy After
`Intravenous Diuresis. Retina Cases and Brief Reports ,2010(2):174-7
`
`16. Do DV, Schmidt-Erfurth U, Gonzalez VH, Gordon CM, Tolentino M, Berliner AJ, Vitti
`R, Rückert R, Sandbrink R, Stein D, Ke Yang K, Beckmann K, Heier JS.
`The DA VINCI Study: Phase 2 Primary Results of VEGF Trap-Eye in Patients with
`Diabetic Macular Edema. Ophthalmology, 2011;118(9):1819-1826.
`
`17. Hatef E, Ibrahim, Nguyen QD, Do DV. Diagnostic and therapeutic challenges.
`Neovascular age-related macular degeneration with pigment epithelial detachment. Retina
`2011 Jun;31(6)1218-1223
`
`
`Regeneron Exhibit 2002
`Page 05 of 40
`
`

`

`Diana V. Do, MD
`February 8, 2021
`
`
`
`
`6
`
`
`
`
`18. Chen LY, Kesen MR, Ghafourian A, Nguyen QD, Eberhart CG, Do DV. Isolated
`endogenous Nocardia endophthalmitis after immunosuppression.
`J Ophthalmic Inflamm Infect. 2012 Sep;2(3)141-143
`
`19. Do DV, Gower EW, Cassard SD, Boyer D, Bressler NM, Bressler SB, Heier JS,
`Jefferys JL, Singerman LJ, Solomon SD. Detection of new-onset choroidal
`neovascularization using optical coherence tomography: the AMD DOC Study.
`Ophthalmology. 2012 Apr;119(4):771-8.
`
`20. Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R, Berliner AJ, Gao
`B, Zeitz O, Ruckert R, Schmelter T, Sandbrink R, Heier JS; DAVINCI Study Group*. One-
`Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular
`Edema. Ophthalmology. 2012 Aug;119(8):1658-65.
`
`21. Paskowitz DM, Nguyen QD, Gehlbach P, Handa JT, Solomon S, Stark W, Shaikh O,
`Semba C, Gadek TR, Do DV. Safety, tolerability, and bioavailability of topical SAR 1118, a
`novel antagonist of lymphocyte function-associated antigen-1: a phase 1b study. Eye
`(Lond). 2012 Apr 27. doi: 10.1038/eye.2012.68.
`
`22. Do DV, Nguyen QD, Khwaja AA, Channa R, Sepah YJ, Sophie R, Hafiz G,
`Campochiaro PA; for the READ-2 Study Group. Ranibizumab for Edema of the Macula in
`Diabetes Study: 3-Year Outcomes and the Need for Prolonged Frequent Treatment.
`JAMA Ophthalmol. 2013 Feb;131(2):139-45.
`
`23. Do DV, Greenwald L, Ibrahim M, Sepah Y, Nguyen QD. Choroidal neovascularization
`regression on fluorescein angiography after VEGF blockade.
`Case Rep Ophthalmol. 2012 Sep;3(3):384-8.
`
`24. Nguyen QD, Ibrahim MA, Watters A, Bittencourt M, Yohannan J, Sepah YJ, Dunn JP,
`Naor J, Shams N, Shaikh O, Leder HA, Do DV. Ocular tolerability and efficacy of
`intravitreal and subconjunctival injections of sirolimus in patients with non-infectious
`uveitis: primary 6-month results of the SAVE Study. J Ophthalmic Inflamm Infect. 2013
`Feb 11;3(1):32.
`
`25. Do DV. Detection of new-onset choroidal neovascularization. Curr Opin Ophthalmol.
`2013 May;24(3):244-7.
`
`27. Implications Of The Comparisons Of Age-Related Macular Degeneration Treatments
`Trials On Clinical Practice: What Have We Learned?
`Do DV. Ophthalmology. 2013 May;120(5 Suppl):S8-10. Doi:
`10.1016/J.Ophtha.2013.01.058.
`
`28. Do DV, Pieramici DJ, Van Lookeren Campagne M, Beers T, Friesenhahn M, Zhang Y,
`Strauss EC; For The Phase Ia Investigators. A Phase Ia Dose-Escalation Study Of The
`Anti-Factor D Monoclonal Antibody Fragment Fcfd4514s In Patients With Geographic
`Atrophy. Retina. 2014;34(2)313-320
`
`29. Surgery for post-vitrectomy cataract.
`Do DV, Gichuhi S, Vedula SS, Hawkins BS.
`Cochrane Database Syst Rev. 2013 Dec 19;12:
`
`Regeneron Exhibit 2002
`Page 06 of 40
`
`

`

`Diana V. Do, MD
`February 8, 2021
`
`
`
`
`7
`
`
`
`
`
`
`30. Do DV, Bressler SB, Cassard SD, Gower EW, Tabandeh H, Jefferys JL, Bressler NM.
`Ranibizumab For Macular Telangiectasia Type 2 In The Absence Of Subretinal
`Neovascularization. Retina. 2014 Oct;34(10):2063-71.
`
`31. Gonzalez VH, Boyer DS, Schmidt-Erfurth U, Heier JS, Gordon C, Benz MS, Marcus
`DM, Sabates NR, Vitti R, Kazmi H, Berliner AJ, Soo Y, Zhu X, Moini H, Zeitz O, Sandbrink
`R, Do DV. Microperimetric assessment of retinal sensitivity in eyes with diabetic macular
`edema from a phase 2 study of intravitreal aflibercept.
`Retina. 2015 Apr;35(4):687-94
`
`32. Do DV, Sepah YJ, Boyer D, Callanan D, Gallemore R, Bennett M, Marcus DM,
`Halperin L, Sadiq MA, Rajagopalan N, Campochiaro PA, Nguyen QD.
`Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula
`in Diabetes-Protocol 3 with high dose).
`Eye (Lond). 2015 Dec;29(12):1538-44.
`
`33. Do DV, Nguyen QD, Vitti R, Berliner AJ, Gibson A, Saroj N, Soo Y, Boyer DS.
`Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior
`Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 Program.
`Ophthalmology. 2016 Apr;123(4):850-7.
`
`34. Sepah YJ, Sadiq MA, Boyer D, Callanan D, Gallemore R, Bennett M, Marcus D,
`Halperin L, Hassan M, Campochiaro PA, Nguyen QD, Do DV; READ-3 Study Group.
`Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes -
`Protocol 3 with High Dose (READ-3) Study. Ophthalmology. 2016 Dec;123(12):2581-
`2587.
`
`35. Hassan M, Agarwal A, Afridi R, daSilva MJ, Karaca I, Sadiq MA, Nguyen QD, Do DV.
`The Role of Optical Coherence Tomography Angiography in the Management of Uveitis.
`Int Ophthalmol Clin. 2016 Fall;56(4):1-24.
`
`36. Sepah YJ, Sadiq MA, Boyer D, Callanan D, Gallemore R, Bennett M, Marcus D,
`Halperin L, Hassan M, Campochiaro PA, Nguyen QD, Do DV; READ-3 Study Group.
`Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes -
`Protocol 3 with High Dose (READ-3) Study. Ophthalmology. 2016 Dec;123(12):2581-
`2587. doi: 10.1016/j.ophtha.2016.08.040. Epub 2016 Oct 1.
`
`37. Rhoades W, Dickson D, Nguyen QD, Do DV. Management of macular edema due to
`central retinal vein occlusion - The role of aflibercept.Taiwan J Ophthalmol. 2017 Apr-
`Jun;7(2):70-76. doi: 10.4103/tjo.tjo_9_17. Review.
`
`38. Arkfeld D, Rhoades W, Baldwin A, Do DV. A case of complex macula-off retinal
`detachment following traumatic globe rupture. Am J Ophthalmol Case Rep. 2016 Nov
`19;6:33-34. doi: 10.1016/j.ajoc.2016.11.002. eCollection 2017 Jun
`
`39. Shields RA, Smith SJ, Pan CK, Do DV. Endogenous klebsiella pneumoniae
`endophthalmitis in Northern California.
`Retina. 2019 Mar;39(3):614-620. doi: 10.1097/IAE. 0000000000001994.PMID: 29232335.
`
`40. Do DV, Gichuhi S, Vedula SS, Hawkins BS. Surgery for postvitrectomy cataract.
`
`Regeneron Exhibit 2002
`Page 07 of 40
`
`

`

`Diana V. Do, MD
`February 8, 2021
`
`
`
`
`8
`
`
`
`
`Cochrane Database Syst Rev. 2018 Jan 10;1:CD006366. doi:
`10.1002/14651858.CD006366.pub4.
`
`41. Tang PH, Hariprasad SM, Do DV. Rethinking Management Strategies for Proliferative
`Diabetic Retinopathy.
`Ophthalmic Surg Lasers Imaging Retina. 2018 Apr 1;49(4):224-227. doi:
`10.3928/23258160-20180329-01.
`
`42. Nguyen QD, Merrill PT, Sepah YJ, Ibrahim MA, Banker A, Leonardi A, Chernock M,
`Mudumba S, Do DV. Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis:
`Evolution through Preclinical and Clinical Studies. Ophthalmology. 2018 Jul 27. pii: S0161-
`6420(17)33538-8. doi: 10.1016/j.ophtha.2018.06.015.
`
`43. Sarwar S, Hassan M, Soliman MK, Halim MS, Sadiq MA, Afridi R, Agarwal A, Do DV.
`Diurnal variation of choriocapillaris vessel flow density in normal subjects measured using
`optical coherence tomography angiography. Int J Retina Vitreous. 2018 Oct 10;4:37. doi:
`10.1186/s40942-018-0140-0. eCollection 2018.PMID: 30338130
`
`44. Csaky KG, Patel PJ, Sepah YJ, Birch DG, Do DV. Microperimetry for geographic
`atrophy secondary to age-related macular degeneration. Surv Ophthalmol. 2019 May-
`Jun;64(3):353-364.
`
`45. Hassan M, Karkhur S, Bae JH, Halim MS, Ormaechea MS, Onghanseng N, Nguyen
`NV, Afridi R, Sepah YJ, Do DV. New therapies in development for the management of
`non-infectious uveitis: A review. Clin Exp Ophthalmol. 2019 Apr;47(3):396-417. doi:
`10.1111/ceo.13511.PMID: 30938012.
`
`46. Hassan M, Nguyen NV, Halim MS, Afridi R, Sadiq MA, Karkhur S, Vigil E,
`Karabekirogullari S, Nguyen QD, Do DV. Effect of vitreomacular adhesion on the
`treatment outcome in the STOP-Uveitis clinical trial for non-infectious uveitis. J Ophthalmic
`Inflamm Infect. 2019 Jul 19;9(1):12. doi: 10.1186/s12348-019-0179-6.PMID: 31325001.
`
`47. Nguyen QD, Sepah YJ, Berger B, Brown D, Do DV. Primary outcomes of the VIDI
`study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for
`diabetic macular edema. Int J Retina Vitreous. 2019 Aug 1;5:28. doi: 10.1186/s40942-019-
`0178-7. eCollection 2019.PMID: 31388454.
`
`48. Karkhur S, Hasanreisoglu M, Vigil E, Halim MS, Hassan M, Plaza C, Nguyen NV,
`Afridi R, Tran AT, Do DV. Interleukin-6 inhibition in the management of non-infectious
`uveitis and beyond. J Ophthalmic Inflamm Infect. 2019 Sep 16;9(1):17. doi:
`10.1186/s12348-019-0182-y.PMID: 31523783.
`
`49. Yeh S, Kurup SK, Wang RC, Foster CS, Noronha G, Nguyen QD, Do DV.
`Suprachoroidal injection of triamcinolone acetonide, CLS-TA fo macular edema due to
`noninfectious uveitis: A Randomized, Phase 2 Study (DOGWOOD). Retina. 2019
`Oct;39(10):1880-1888. doi: 10.1097/IAE.0000000000002279.PMID: 30113933.
`
`
`Regeneron Exhibit 2002
`Page 08 of 40
`
`

`

`Diana V. Do, MD
`February 8, 2021
`
`
`
`
`9
`
`
`
`
`50. Kuppermann BD, Bernstein P, Mones J, Do DV. ISOPT Clinical Hot Topic Panel
`Discussion on Medical Treatment of RETINAL Diseases. J Ocul Pharmacol Ther. 2019
`Oct;35(8):424-432. doi: 10.1089/jop.2019.0073.PMID: 31596664.
`
`51. Ormaechea MS, Hassan M, Onghanseng N, Park JH, Mahajan S, Al-Kirwi KY, Uludag
`G, Halim MS, Schlaen A, Sepah YJ, Do DV. Safety of systemic therapy for noninfectious
`uveitis. Expert Opin Drug Saf. 2019 Dec;18(12):1219-1235. doi:
`10.1080/14740338.2019.1692810.PMID: 31801415.
`
`52. Ludwig CA, Shields RA, Do DV. Traumatic chorioretinitis sclopetaria: Risk factors,
`management, and prognosis. Am J Ophthalmol Case Rep. 2019 Feb 16;14:39-46.
`
`53. Nguyen NV, Vigil EM, Hassan M, Halim MS, Baluyot SC, Guzman HA, Afridi R, Do
`DV. Comparison on montage with conventional stereoscopic seven-field photographs for
`assessment of ETDRS diabetic retinopathy severity. Int J Retina Vitreous. 2019 Dec
`13;5:51. doi: 10.1186/s40942-019-0201-z. eCollection 2019.PMID: 31890280.
`
`54. Nguyen QD, Das A, Do DV. Brolucizumab: Evolution through Preclinical and Clinical
`Studies and the Implications for the Management of Neovascular Age-Related Macular
`Degeneration. Ophthalmology. 2020 Jul;127(7):963-976. doi:
`10.1016/j.ophtha.2019.12.031. Epub 2020 Jan 17.PMID: 32107066.
`
`55. Do DV, Rhoades W, Nguyen QD. Pharmacokinetic study of intravitreal aflibercept in
`humans with neovascular age-related macular degeneration. Retina. 2020 Apr;40(4):643-
`647.
`
`56. Carter KL, Do DV. Hydroxychloroquine-induced Retinal Toxicity. J Rheumatol. 2020
`Apr;47(4):632. doi: 10.3899/jrheum.190538.PMID: 32238544.
`
`57. Li AS, Tang PH, Do DV. Serous Macular Detachment in Probable Vogt-Koyanagi-
`Harada Syndrome. JAMA Ophthalmol. 2020 May 1;138(5):e191981. doi:
`10.1001/jamaophthalmol.2019.1981. Epub 2020 May 14.PMID: 32407448.
`
`58. Hassan M, Chakravarthy AD, Subramaniam M, Chundi P, Sadiq MA, Halim MS, Afridi
`R, Tran ANT, Sepah YJ, Do DV. Correction of perceived visual distortions using a
`software application and correlation to age-related macular degeneration. Ther Adv
`Ophthalmol. 2020 May 18;12:2515841420917783. doi: 10.1177/2515841420917783.
`eCollection 2020 Jan-Dec.PMID: 32524073.
`59. Li AS, Nguyen HV, Do DV. Migration of a Fluocinolone Acetonide Intravitreal
`Implant.in the Anterior Chamber. JAMA Ophthalmol. 2020 Oct 1;138(10):e201388. doi:
`10.1001/jamaophthalmol.2020.1388. Epub 2020 Oct 8.
`
`60. Li AS, Tang PH, Do DV. Serous Macular Detachment in Probable Vogt-Koyanagi-
`Harada Syndrome. JAMA Ophthalmol. 2020 May 1;138(5):e191981. doi:
`10.1001/jamaophthalmol.2019.1981. Epub 2020 May 14.
`
`
`Regeneron Exhibit 2002
`Page 09 of 40
`
`

`

`Diana V. Do, MD
`February 8, 2021
`
`
`
`
`10
`
`
`
`
`61. Moujahad AA, Vader D, Do, DV. Racial Differences in Anti-Vascular Endothelial
`Growth Factor Intravitreal Injections Among Commercially Insured Beneficiaries.
`Ophthalmic Surgery, Laser, and Imaging Retina Jan. 2021 (accepted for publication)
`
`62. Lin CC, Li AS, Ma H, Lin X, Olivares M, Haubrich A, Sanislo S, Do DV. Successful
`interventions to improve efficiency and reduce patient visit duration in a retina practice.
`Retina 2021 (accepted for publication).
`
`
`Middle author peer-review journal articles (Total: 78; Total at Stanford: 5)
`
`63. Jun AS, Liu SH, Koo EH, Do DV, Stark WJ, Gottsch JD. “Microarray Analysis of Gene
`Expression in Human Donor Corneas.” Archives of Ophthalmology 2001;119:1629-1634.
`Role in study: participated in design, interpretation of results, writing and review of
`manuscript.
`
`64. Jun AS, Broman KW, Do DV, Akpek EK, Stark WJ, Gottsch JD. “Endothelial
`Dystrophy, Iris Hypoplasia, Congenital Cataract, and Stromal Thinning Syndrome (EDICT)
`Maps to Chromosome 15q22.1-q25.3” American Journal of Ophthalmology
`2002;134(2):172-176. Role in study: participated in design, interpretation of results, writing
`and review of manuscript.
`
`65. Akpek EK, Thorne JE, Qazi FA, Do DV, Jabs DA. “Evaluation of patients with scleritis
`for systemic disease.” Ophthalmology 2004;111(3):501-506. Role in study: participated in
`design, interpretation of results, writing and review of manuscript.
`
`66. Nguyen QD, Shah S, Tatlipinar S, Do DV, Anden EV, Campochiaro PA. “Bevacizumab
`suppresses choroidal neovascularization caused by pathologic myopia.” British Journal of
`Ophthalmology 2005;89(10):1368-70. Role in study: participated in design, interpretation
`of results, writing and review of manuscript.
`
`67. Ober MD, Yannuzzi LA, Do DV, Spaide RF, Bressler NM, Jampol LM, Angellili A,
`Eandi CM, Lyon AT. “Photodynamic therapy for focal retinal pigment epithelial leaks
`secondary to central serous chorioretinopathy.” Ophthalmology 2005;112:2088-2094. Role
`in study: participated in design, interpretation of results, writing and review of manuscript.
`
`68. Nguyen QD, Tatlipinar S, Shah SM, Haller JA, Quinlan E, Sung JU, Zimmer-Galler I,
`Do DV, Campochiaro PA. Vascular endothelial growth factor is a critical stimulus for
`diabetic macular edema. American Journal of Ophthalmology 2006;142:961-969. Role in
`study: participated in design, interpretation of results, writing and review of manuscript.
`
`69. Gerstenblith AT, Thorne JE, Sobrin L, Do DV, Shah SM, Foster CS, Jabs DA, Nguyen
`QD. Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology.
`2007;114(6):1201-4. Role in study: participated in design, interpretation of results, writing
`and review of manuscript.
`
`70. Nguyen QD, Shah SM, Hafiz G, Do DV, Haller JA, Pili R, Zimmer-Galler I, Janjua K,
`Symons RCA, Campochiaro PA. Intravenous bevacizumab causes regression of
`choroidal neovascularization secondary to diseases other than age-related macular
`degeneration. American Journal of Ophthalmology 2008; 145(2): 257-266. Role in study:
`participated in design, interpretation of results, writing and review of manuscript.
`
`Regeneron Exhibit 2002
`Page 10 of 40
`
`

`

`Diana V. Do, MD
`February 8, 2021
`
`
`
`
`11
`
`
`
`
`
`71. Campochiaro PA, Hafiz G, Shah SM, Nguyen QD, Ying H, Do DV, Quinlan
`E, Zimmer-Galler I, Haller JA, Solomon SD, Sung JU, Hadi Y, Janjua KA, Jawed N, Choy
`DF, Arron JR. Ranibizumab for macular edema due to Retinal Vein Occlusions;
`Implication of VEGF as a Critical Stimulator. Molecular Therapy 2008; Apr;16(4):791-9
`Role in study: participated in design, interpretation of results, writing and review of
`manuscript.
`
`72. Sodhi A, Leung LS, Do DV, Gower EW, Schein OD, Handa JT. Recent trends in the
`management of rhegmatogenous retinal detachment. Surv Ophthalmol. 2008 Jan-
`Feb;53(1):50-67. Role in study: participated in design, interpretation of results, writing and
`review of manuscript.
`
`73. Nguyen-Khoa BA, Goerhing EL Jr, Wether W, Gower EW, Do DV, Jones, JK.
`Hospitalized cardiovascular diseases in age-related macular degeneration. Arch
`Ophthalmol. 2008;126:1280-1286. Role in study: participated in design, interpretation of
`results, writing and review of manuscript.
`
`
`
`74. Khurana RN, Do DV, Nguyen QD. Anti-VEGF therapeutic approaches for diabetic
`macular edema. Int Ophthalmol Clin. 2009 Spring;49(2):109-19. Role in study: participated
`in design, interpretation of results, writing and review of manuscript.
`
`75. Nguyen QD, Shah SM, Browning DJ, Hudson H, Sonkin P, Hariprasad SM, Kaiser P,
`Slakter JS, Haller J, Do DV, Mieler WF, Chu K, Yang K, Ingerman A, Vitti RL, Berliner AJ,
`Cedarbaum JM, Campochiaro PA. A Phase I Study of Intravitreal Vascular Endothelial
`Growth Factor Trap-Eye in Patients with Neovascular Age-Related Macular Degeneration.
`Ophthalmology. 2009 Nov;116(11):2141-8.e1 Role in study: participated in design,
`interpretation of results, writing and review of manuscript.
`
`76. Campochiaro PA, Choy DF, Do DV, Hafiz G, Shah SM, Nguyen QD, Rubio R, Arron
`JR. Monitoring Ocular Drug Therapy by Analysis of Aqueous Samples. Ophthalmology.
`2009 Nov;116(11):2158-64. Role in study: participated in design, interpretation of results,
`writing and review of manuscript.
`
`77. Nguyen QD, Shah SM, Heier JS, Do DV, Lim J, Boyer D, Abraham P, Campochiaro
`PA; READ-2 Study Group. Primary End Point (Six Months) Results of the Ranibizumab for
`Edema of the mAcula in Diabetes (READ-2) Study. Ophthalmology. 2009
`Nov;116(11):2175-81.e1. Role in study: participated in design, interpretation of results,
`writing and review of manuscript.
`
`78. Kashani AH, Zimmer-Galler IE, Shah SM, Dustin L, Do DV, Eliott D, Haller JA, Nguyen
`QD. Retinal thickness analysis by race, gender, and age using Stratus OCT. Am J
`Ophthalmol. 2010 Mar;149(3):496-502.e1. Role in study: participated in design,
`interpretation of results, writing and review of manuscript.
`
`79. Shah SM, Nguyen QD, Mir HS, Polito A, Hafiz G, Tatlipinar S, Do DV, Vitale S, Haller
`JA. A randomized, double-masked controlled clinical trial of Sandostatin long-acting
`release depot in patients with postsurgical cystoid macular edema.
`
`Regeneron Exhibit 2002
`Page 11 of 40
`
`

`

`Diana V. Do, MD
`February 8, 2021
`
`
`
`
`12
`
`
`
`
`Retina. 2010 Jan;30(1):160-6. Role in study: participated in design, interpretation of
`results, writing and review of manuscript.
`
`80. Campochiaro PA, Shah SM, Hafiz G, Heier JS, Lit ES, Zimmer-Galler I, Channa R,
`Nguyen QD, Syed B, Do DV, Lu L, Monk J, Cooke JP, Kengatharan MK, Hsu HH. Topical
`mecamylamine for diabetic macular edema. Am J Ophthalmol. 2010 May;149(5):839-
`51.e1. Role in study: participated in design, interpretation of results, writing and review of
`manuscript.
`
`81. Kaiser PK, Symons RC, Shah SM, Quinlan EJ, Tabandeh H, Do DV, Reisen G,
`Lockridge JA, Short B, Guerciolini R, Nguyen QD; Sirna-027 Study Investigators. RNAi-
`based treatment for neovascular age-related macular degeneration by Sirna-027. Am J
`Ophthalmol. 2010 Jul;150(1):33-39. Role in study: participated in design, interpretation of
`results, writing and review of manuscript.
`
`82. Campochiaro PA, Hafiz G, Channa R, Shah SM, Nguyen QD, Ying H, Do DV, Zimmer-
`Galler I, Solomon SD, Sung JU, Syed B. Antagonism of Vascular Endothelial Growth
`Factor for Macular Edema Caused by Retinal Vein Occlusions: Two-Year
`Outcomes.Ophthalmology. 2010 Jul 12. Role in study: participated in design, interpretation
`of results, writing and review of manuscript. I was also a co-investigator.
`
`83. Wang J, Ibrahim M, Turkcuoglu P, Hatef E, Khwaja A, Channa R, Do DV, Nguyen
`QD. Intercellular adhesion molecule inhibitors as potential therapy for refractory uveitic
`macular edema. Ocul Immunol Inflamm. 2010 Oct;18(5):395-8. Role in study: participated
`in design, interpretation of results, writing and review of manuscript.
`
`84. Chang MA, Do DV, Bressler SB, Cassard SD, Gower EW, Bressler NM. Prospective
`one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular
`lesions in age-related macular degeneration. Retina. 2010 Sep;30(8):1171-6. Role in
`study: participated in design, interpretation of results, writing and review of manuscript.
`
`85. Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV, Boyer D, Heier JS,
`Abraham P, Thach AB, Lit ES, Foster BS, Kruger E, Dugel P, Chang T, Das A, Ciulla TA,
`Pollack JS, Lim JI, Eliot D, Campochiaro PA; READ-2 Study Group. Two-year outcomes
`of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology.
`2010 Nov;117(11):2146-51. Role in study: participated in design, interpretation of results,
`writing and review of manuscript.
`
`86. Ramulu PY, Do DV, Corcoran KJ, Corcoran SL, Robin AL. Use of retinal procedures
`in medicare beneficiaries from 1997 to 2007. Arch Ophthalmol. 2010 Oct;128(10):1335-40.
`Role in study: participated in design, interpretation of results, writing and review of
`manuscript.
`
`87. Werther W, Chu L, Holekamp N, Do DV, Rubio RG. Myocardial infarction and
`cerebrovascular accident in patients with retinal vein occlusion. Arch Ophthalmol.
`2011;129(3)326-331. Role in study: participated in design, interpretation of results, writing
`and review of manuscript.
`
`88. Hatef E, Turkcuoglu P, Ibrahim M, Sepah Y, Shulman M, Heo J, Lee JH, Channa R,
`Khwaja A, Rentiya Z, Shah SM, Do DV, Nguyen QD. Importance of proper diagnosis for
`management: multifocal choroiditis mimicking ocular histoplasmosis syndrome. J
`
`Regeneron Exhibit 2002
`Page 12 of 40
`
`

`

`Diana V. Do, MD
`February 8, 2021
`
`
`
`
`13
`
`
`
`
`Ophthalmic Inflamm Infect. 2011;1(2):55-63. Role in study: participated in design,
`interpretation of results, writing and review of manuscript.
`
`89. Turkcuoglu P, Chang PY, Rentiya ZS, Channa R, Ibrahim M, Hatef E, Sophie R,
`Sadaka A, Wang J, Sepah YJ, Do DV, Foster CS, Nguyen QD. Mycophenolate mofetil
`and fundus autofluorescence in the management of recurrent punctate inner
`choroidopathy. Ocul Immunol Inflamm.2011;19(4):286-292. Role in study: participated in
`design, interpretation of results, writing and review of manuscript.
`
`90. Ibrahim MA, Sepah YJ, Symons RC, Channa R, Hatef E, Khwaja A, Bittencourt M,
`Heo J, Do DV, Nguyen QD. Spectral- and time-domain optical coherence tomography
`measurements of macular